FULC — Fulcrum Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Annual balance sheet for Fulcrum Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	113	218	203	236	241
Net Total Accounts Receivable
Net Total Receivables	2.71	4.11	1.08	2.25	3.34
Prepaid Expenses
Total Other Current Assets
Total Current Assets	120	226	208	242	250
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	8.4	7.37	16	12.4	9.58
Other Long Term Assets
Total Assets	130	235	227	258	261
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	26.7	19.2	16.7	13.7	11
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	34.4	23.5	27.7	22.5	17.7
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	95.2	212	199	235	243
Total Liabilities & Shareholders' Equity	130	235	227	258	261
Total Common Shares Outstanding